Title:
SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES
Document Type and Number:
WIPO Patent Application WO/2012/013713
Kind Code:
A3
Abstract:
The invention relates to imidazo[1,2-b]pyridazines of general formula (I) a process for their manufacuture and their use for the treatment of benign and malignant neoplasia.
Inventors:
REHWINKEL HARTMUT (DE)
HAEGEBARTH ANDREA (DE)
POLITZ OLIVER (DE)
NEUHAUS ROLAND (DE)
BOEMER ULF (DE)
HAEGEBARTH ANDREA (DE)
POLITZ OLIVER (DE)
NEUHAUS ROLAND (DE)
BOEMER ULF (DE)
Application Number:
PCT/EP2011/062927
Publication Date:
April 12, 2012
Filing Date:
July 27, 2011
Export Citation:
Assignee:
BAYER PHARMA AG (DE)
REHWINKEL HARTMUT (DE)
HAEGEBARTH ANDREA (DE)
POLITZ OLIVER (DE)
NEUHAUS ROLAND (DE)
BOEMER ULF (DE)
REHWINKEL HARTMUT (DE)
HAEGEBARTH ANDREA (DE)
POLITZ OLIVER (DE)
NEUHAUS ROLAND (DE)
BOEMER ULF (DE)
International Classes:
C07D487/04; A61K31/5025
Domestic Patent References:
| WO2008052734A1 | 2008-05-08 | |||
| WO2010114780A1 | 2010-10-07 |
Foreign References:
| US20090318410A1 | 2009-12-24 |
Other References:
KATE F BYTH ET AL: "Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 14, no. 9, 3 May 2004 (2004-05-03), pages 2249 - 2252, XP002567211, ISSN: 0960-894X, [retrieved on 20040305], DOI: 10.1016/J.BMCL.2004.02.008
Attorney, Agent or Firm:
BAYER PHARMA AKTIENGESELLSCHAFT (Patents and LicensingMüllerstrasse 178, Berlin, DE)
Download PDF: